AI prescribing: clinical oversight must not be removed without robust evidence
BMJ · 13.11.2026 · 395 · e101445
DOI: 10.1136/bmj-2026-101445 ↗Kurz gefasst
Editorial in der Zeitschrift BMJ, online erschienen am 13.11.2026. Verfasst von Perisa Ashar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Georgia Institute of Technology, Atlanta, GA, USA. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
A pilot in Utah could allow an AI tool to prescribe acne treatment with limited input from doctors, but evidence justifying its use must withstand scrutiny
Autor:innen und Institutionen
- Georgia Institute of Technology, Atlanta, GA, USA.
- Rutgers University, New Brunswick, NJ, USA.
- McMaster University, Hamilton, ON, Canada.
- Harvard TH Chan School of Public Health, Boston, MA, USA.
- University of California, San Francisco, CA, USA.
Zitieren
APA
Ashar, P., Abbasi, M., Illamperuma, I., Nguyen, D., & Lowder, E. (2026). AI prescribing: clinical oversight must not be removed without robust evidence. BMJ, 395, e101445. https://doi.org/10.1136/bmj-2026-101445
Vancouver
Ashar P, Abbasi M, Illamperuma I, Nguyen D, Lowder E. AI prescribing: clinical oversight must not be removed without robust evidence. BMJ. 2026;395:e101445. doi:10.1136/bmj-2026-101445
BibTeX
@article{Ashar2026,
author = {Ashar, Perisa and Abbasi, Mateen and Illamperuma, Imeth and Nguyen, Dang and Lowder, Ethan},
title = {AI prescribing: clinical oversight must not be removed without robust evidence},
journal = {BMJ},
year = {2026},
volume = {395},
pages = {e101445},
doi = {10.1136/bmj-2026-101445}
}
EUVIMED